In Between the Light and the Dark: Developments in Photosensitive Pharmaceuticals

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-12-02-2004, Volume 28, Issue 11

Researchers are improving photodynamic therapies with new photosensitizers and light sources for deeper tissue penetration, more site-specific treatments, and reduced side effects.

Related Content:

FormulationManufacturingDevelopmentPharmaceutical Technology-12-02-2004
Increasing mRNA Product Stability with Lyophilization
Bristol Myers Squibb to Access Cellares' Cell Therapy Manufacturing Platform in New $380 Million CAR-T Cell Therapy Deal
INTERPHEX 2024: Implementing Contamination Control Strategies in Cell and Gene Therapy Facilities